Zobrazeno 1 - 10
of 264
pro vyhledávání: '"M. Gaubitz"'
Autor:
Xenofon Baraliakos, Martin Feuchtenberger, A. Voigt, Matthias Schneider, H.-M. Lorenz, Jürgen Braun, Kirsten Hoeper, Ch. Specker, E. Tiessen, Matthias Dreher, Torsten Witte, M. Rihl, Andreas Krause, Oliver Sander, M Gaubitz, G. Assmann, V. Lion, K. Benesova, F. Haas, Jan Leipe, A. Nigg, S. Briem, P. Bartz-Bazzanella, Dirk Meyer-Olson, Andreas Schwarting, Reinhold E. Schmidt
Publikováno v:
Zeitschrift für Rheumatologie. 78:722-742
In order to reduce the prognostically relevant time interval between the initial manifestation of a rheumatic and musculoskeletal disease and diagnosis as well as the consecutive initiation of an appropriate treatment, several rheumatological centers
Autor:
K, Benesova, H-M, Lorenz, V, Lion, A, Voigt, A, Krause, O, Sander, M, Schneider, M, Feuchtenberger, A, Nigg, J, Leipe, S, Briem, E, Tiessen, F, Haas, M, Rihl, D, Meyer-Olson, X, Baraliakos, J, Braun, A, Schwarting, M, Dreher, T, Witte, G, Assmann, K, Hoeper, R E, Schmidt, P, Bartz-Bazzanella, M, Gaubitz, C, Specker
Publikováno v:
Zeitschrift fur Rheumatologie. 78(8)
In order to reduce the prognostically relevant time interval between the initial manifestation of a rheumatic and musculoskeletal disease and diagnosis as well as the consecutive initiation of an appropriate treatment, several rheumatological centers
Autor:
M, Gaubitz
Publikováno v:
Zeitschrift fur Rheumatologie. 78(3)
Osteoporosis is one of the most frequent comorbidities in inflammatory rheumatic diseases. The immune system is substantially involved in the regulation of bone homeostasis and chronic inflammatory diseases influence this equilibrium at several level
Publikováno v:
Zeitschrift fur Rheumatologie. 78(6)
The efficacy and safety of the TNF‑α inhibitor etanercept (ETA) as a treatment for rheumatoid arthritis (RA) is well established by randomized controlled trials. The purpose of this study was to evaluate the benefit yielded by ETA within the regul
Autor:
C, Fiehn, J, Holle, C, Iking-Konert, J, Leipe, C, Weseloh, M, Frerix, R, Alten, F, Behrens, C, Baerwald, J, Braun, H, Burkhardt, G, Burmester, J, Detert, M, Gaubitz, A, Gause, E, Gromnica-Ihle, H, Kellner, A, Krause, J, Kuipers, H-M, Lorenz, U, Müller-Ladner, M, Nothacker, H, Nüsslein, A, Rubbert-Roth, M, Schneider, H, Schulze-Koops, S, Seitz, H, Sitter, C, Specker, H-P, Tony, S, Wassenberg, J, Wollenhaupt, K, Krüger
Publikováno v:
Zeitschrift fur Rheumatologie. 77(Suppl 2)
Medication-based strategies to treat rheumatoid arthritis are crucial in terms of outcome. They aim at preventing joint destruction, loss of function and disability by early and consistent inhibition of inflammatory processes.Achieving consensus abou
Publikováno v:
European Journal of Pain (London, England)
Background Until now, nonivamide/nicoboxil ointment has not been tested in a randomized trial for the treatment of acute non-specific low back pain. Methods This phase III randomized, double-blind, active- and placebo-controlled, multi-centre trial i
Autor:
M. Gaubitz
Publikováno v:
Lupus erythematodes ISBN: 9783662538432
Bei vielen Rheumaerkrankungen erkannte man in den letzten Jahren, dass eine Beteiligung innerer Organe fern der Gelenke vorliegt. Dies fuhrt zu uberraschenden Empfehlungen wie zum Beispiel, Patienten mit rheumatoider Arthritis regelmasig auf eine mog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::520e329093f26f11ebe06dfa545f47dc
https://doi.org/10.1007/978-3-662-53844-9_13
https://doi.org/10.1007/978-3-662-53844-9_13
Autor:
Kommission Pharmakotherapie der DGRh, Frank Dressler, A. Krause, M. Gaubitz, Hans Iko Huppertz
Publikováno v:
Zeitschrift für Rheumatologie. 73:469-474
These guidelines summarize the current evidence for diagnosis and treatment of Lyme arthritis and the most frequent skin manifestations of Borrelia burgdorferi infections. Lyme arthritis is a monoarticular or oligoarticular form of arthritis that typ